<html>
<head>PUBMED IDs for MTHFD2</head>
<body bgcolor='#C5F0F2'><h1>MTHFD2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/19252927/'>Bladder cancer SNP panel predicts susceptibility and survival.</a> May 27  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20144594/'>Factors determining sensitivity or resistance of tumor cell lines towards artesunate.</a> May 11  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20198662/'>Quantitative proteomics study of breast cancer cell lines isolated from a single patient: discovery of TIMM17A as a marker for breast cancer.</a> July 20  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21105050/'>A candidate CpG SNP approach identifies a breast cancer associated ESR1-SNP.</a> September 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21163947/'>Mammalian MTHFD2L encodes a mitochondrial methylenetetrahydrofolate dehydrogenase isozyme expressed in adult tissues.</a> April 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22761433/'>MicroRNA-9 inhibition of cell proliferation and identification of novel miR-9 targets by transcriptome profiling in breast cancer cells.</a> December 10  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23295955/'>High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.</a> August 30  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24451681/'>Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer.</a> October 28  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24688052/'>KRAS mutation status is associated with enhanced dependency on folate metabolism pathways in non-small cell lung cancer cells.</a> February 20  2014<br></body></html>
